IMACLA Trademark

Trademark Overview


On Monday, September 22, 2014, a trademark application was filed for IMACLA with the United States Patent and Trademark Office. The USPTO has given the IMACLA trademark a serial number of 86401856. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 6, 2017. This trademark is owned by Eli Lilly and Company. The IMACLA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, Parkinson's disease, psychiatric disorders, sleep disorders, urological disorders; antidepressants; Diagnostic agents and substances for medical purposes; radiopharmaceutic...
imacla

General Information


Serial Number86401856
Word MarkIMACLA
Filing DateMonday, September 22, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 6, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 3, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, Parkinson's disease, psychiatric disorders, sleep disorders, urological disorders; antidepressants; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 30, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, November 6, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 6, 2017ABANDONMENT - NO USE STATEMENT FILED
Thursday, March 9, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 9, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 8, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 6, 2017EXTENSION 4 GRANTED
Monday, February 6, 2017EXTENSION 4 FILED
Monday, February 6, 2017TEAS EXTENSION RECEIVED
Wednesday, July 13, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 12, 2016EXTENSION 3 GRANTED
Thursday, June 30, 2016EXTENSION 3 FILED
Thursday, June 30, 2016TEAS EXTENSION RECEIVED
Tuesday, February 2, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, January 30, 2016EXTENSION 2 GRANTED
Tuesday, January 26, 2016EXTENSION 2 FILED
Tuesday, January 26, 2016TEAS EXTENSION RECEIVED
Friday, September 11, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 10, 2015EXTENSION 1 GRANTED
Monday, August 24, 2015EXTENSION 1 FILED
Wednesday, September 2, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 24, 2015TEAS EXTENSION RECEIVED
Tuesday, March 31, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 3, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 3, 2015PUBLISHED FOR OPPOSITION
Wednesday, January 14, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 15, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 11, 2014ASSIGNED TO EXAMINER
Tuesday, September 30, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 25, 2014NEW APPLICATION ENTERED IN TRAM